Alnylam Pharmaceuticals
ALNY
#865
Rank
โ‚ฌ25.46 B
Marketcap
190,32ย โ‚ฌ
Share price
0.27%
Change (1 day)
-49.04%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company